Authors: Milliat, F Ferezou, J Delhon, A Lutton, C

Citation: F. Milliat et al., Overexpression of SR-BI in hamsters treated with a novel ACAT inhibitor (F12511), CR AC S III, 324(3), 2001, pp. 229-234

Authors: Junquero, D Bruniquel, F N'Guyen, X Autin, JM Patoiseau, JF Degryse, AD Colpaert, FC Delhon, A

Citation: D. Junquero et al., F 12511, a novel ACAT inhibitor, and atorvastatin regulate endogenous hypercholesterolemia in a synergistic manner in New Zealand rabbits fed a casein-enriched diet, ATHEROSCLER, 155(1), 2001, pp. 131-142

Authors: Ouguerram, K Lutton, C Delhon, A Magot, T

Citation: K. Ouguerram et al., Effects of F2833 on cholesterol metabolism in the genetically hyperlipidemic rat, EUR J PHARM, 415(2-3), 2001, pp. 293-299

Authors: Junquero, D Pilon, A Carilla-Durand, E Patoiseau, JF Tarayre, JP Torpier, G Staels, B Fruchart, JC Colpaert, FC Clavey, V Delhon, A

Citation: D. Junquero et al., Lack of toxic effects of F 12511, a novel potent inhibitor of acylcoenzymeA: cholesterol O-acyltransferase, on human adrenocortical cells in culture, BIOCH PHARM, 61(4), 2001, pp. 387-398

Authors: Junquero, D Oms, P Carilla-Durand, E Autin, JM Tarayre, JP Degryse, AD Patoiseau, JF Colpaert, FC Delhon, A

Citation: D. Junquero et al., Pharmacological profile of F 12511, (S)-2 ',3 ',5 '-trimethyl-4 '-hydroxy-alpha-dodecylthioacetanilide a powerful and systemic acylcoenzyme A: cholesterol acyltransferase inhibitor, BIOCH PHARM, 61(1), 2001, pp. 97-108

Authors: Chang, CCY Sakashita, N Ornvold, K Lee, O Chang, ET Dong, R Lin, S Lee, CYG Strom, SC Kashyap, R Fung, JJ Farese, RV Patoiseau, JF Delhon, A Chang, TY

Citation: Ccy. Chang et al., Immunological quantitation and localization of ACAT-1 and ACAT-2 in human liver and small intestine, J BIOL CHEM, 275(36), 2000, pp. 28083-28092